An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels.

Trial Profile

An Open-label, Single and Multiple Application of Intranasal Testosterone Gel (TBS-2) in Healthy Premenopausal Female Subjects at Three Dose Levels.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Testosterone (Primary)
  • Indications Female sexual dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 13 Jun 2012 NCT reports actual end date is (Feb 2012).
    • 21 Mar 2012 Status changed from active, no longer recruiting to completed, according to a Trimel Pharmaceuticals Corporation media release.
    • 21 Mar 2012 Results published in a Trimel Pharmaceuticals Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top